| Autor: |
Ciancio, Gaetano, Burke, George W., Gaynor, Jeffrey J., Mattiazzi, Adela, Roohipour, Ramin, Carreno, Manuel R., Roth, David, Ruiz, Phillip, Kupin, Warren, Rosen, Anne, Esquenazi, Violet, Tzakis, Andreas G., Miller, Joshua |
| Zdroj: |
Transplantation; August 2004, Vol. 78 Issue: 3 p426-433, 8p |
| Abstrakt: |
In an attempt to reduce both initial and long-term (nephrotoxic) calcineurin inhibitor maintenance dosage and totally eliminate maintenance corticosteroids, alemtuzumab (Campath-1H) was used as induction therapy in first cadaver and non-HLA-identical living donor renal transplantation. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
